Determinants of Daily Physical Activity Level in Patients With Cystic Fibrosis - Pilot Study Protocol

NAActive, not recruitingINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

December 20, 2024

Study Completion Date

December 20, 2024

Conditions
Cystic Fibrosis
Interventions
DEVICE

Accelerometer

For the following study, each patient will be asked to wear a portable device over a 7-day period. The accelerometer will be previously set up according to anthropometric data of the patient and scheduled to automatically start and stop accelerations registration. The patient will be asked to wear the sensor as frequently as possible, with the exception of sleep period and during aquatic activities. A diary will be delivered to the patient in order to notify any problem/issue observed during the evaluation week (for example forgetting to wear the sensor). The accelerometry assessment will be associated to a questionnaire. Each patient will have to fill in it during the evaluation week. The questionnaire is composed of various questions from three different questionnaires: Ricci \& Gagnon for subjective evaluation of PA level, CFQ-14+ for the evaluation of quality of life specifically in CF and EQ-5D for a more generic evaluation of quality of life.

Trial Locations (6)

31059

CHU DE TOULOUSE Hôpital des Enfants - CRCM Pédiatrique, Toulouse

33056

CHU DE BORDEAUX Hôpital des Enfants-Pellegrin - CRCM Pédiatrique, Bordeaux

33600

CHU DE BORDEAUX Hôpital Haut-Lévêque - CRCM Adulte, Bordeaux

87042

CHU DE LIMOGES Hôpital Dupuytren 2 - CRCM Adulte, Limoges

CHU DE LIMOGES Hôpital Mère Enfant - CRCM Pédiatrique, Limoges

Dr

CHU DE TOULOUSE Hôpital Larrey - CRCM Adulte, Toulouse

All Listed Sponsors
lead

University Hospital, Limoges

OTHER